TARSONSTarsons Products Ltd.

    Tarsons Products Q2 FY27 Results: Consolidated Net Loss ₹0.34 Crore on Total Income of ₹128 Crore

    • Earnings
    • plastic laboratory products
    A teaching laboratory with rows of workbenches, sinks and microscopes
    ТимофейЛееСуда, via Wikimedia Commons (CC0 1.0). Illustrative image.

    Tarsons Products (NSE: TARSONS) reported a consolidated net loss of ₹0.34 crore on total income of ₹128.08 crore for the quarter ended 30 Sep 2026, and a standalone net profit of ₹3.09 crore on total income of ₹105.55 crore, it said in a filing on 12 Nov 2026. The consolidated loss compares with a consolidated profit of ₹3.32 crore a year earlier.

    Key highlights

    Consolidated

    Including its subsidiaries

    • Total income: ₹128.08 crore, up 18.5% YoY and 10.2% QoQ
    • Net profit: Loss of ₹0.34 crore against a profit of ₹3.32 crore a year earlier; EPS of ₹-0.06
    • Profit before tax: ₹0.67 crore, down 88.1% YoY
    • Finance costs: ₹6.60 crore, up 27.5% YoY

    Standalone

    The company on its own, without its subsidiaries

    • Total income: ₹105.55 crore, up 20.2% YoY and 13.6% QoQ
    • Net profit: ₹3.09 crore, down 52.7% YoY; EPS of ₹0.58
    • Profit before tax: ₹4.21 crore, down 52.6% YoY
    • Finance costs: ₹5.75 crore, up 30.4% YoY

    Summary

    Consolidated ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    128.08108.13+18.5%116.22+10.2%
    -0.343.32n/a-1.44+76.2%
    EPS, basic (₹)-0.060.62n/a-0.27+77.8%

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Consolidated revenue from operations rose 20.8% YoY to ₹123.65 crore, while other income fell 23.6% to ₹4.43 crore. Other income is 3.5% of total income this quarter, against 5.0% in the standalone results, so the consolidated total income is more weighted to operating revenue than the year-earlier quarter's mix.

    Profit fell faster than income. Consolidated profit before tax fell 88.1% YoY to ₹0.67 crore, and the net result moved to a loss of ₹0.34 crore. Tax expense of ₹1.01 crore is 151.6% of profit before tax, so the tax charge exceeds the pre-tax profit. The filing does not explain why the tax charge is high relative to profit.

    Depreciation rose 25.7% YoY to ₹28.26 crore and finance costs rose 27.5% to ₹6.60 crore. Finance costs are 5.2% of total income this quarter.

    The filing says the consolidated results include Tarsons Life Science Pte. Ltd., Singapore, and two German indirect subsidiaries, Nerbe plus GmbH & Co. KG and Nerbe R&D GmbH. The auditors' conclusion on the consolidated results is not modified; it relies partly on another auditor's review of one subsidiary, and the unreviewed interim information of two subsidiaries is described by management as not material to the Group.

    Standalone ₹ crore
    ParticularsQ2 FY27Q2 FY26YoYQ1 FY27QoQ
    105.5587.82+20.2%92.90+13.6%
    3.096.53-52.7%0.68+354.1%
    EPS, basic (₹)0.581.23-52.8%0.13+346.2%

    Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.

    Standalone revenue from operations rose 24.5% YoY to ₹100.23 crore, while other income fell 27.3% to ₹5.32 crore. Other income is 5.0% of total income this quarter.

    Standalone net profit fell 52.7% YoY to ₹3.09 crore, against total income growth of 20.2%. Depreciation rose 28.5% to ₹25.92 crore and finance costs rose 30.4% to ₹5.75 crore. Standalone tax expense of ₹1.12 crore is 26.7% of profit before tax of ₹4.21 crore, a lower share than in the consolidated figures.

    Against the previous quarter, standalone net profit rose 354.1% from ₹0.68 crore, on total income up 13.6%. Standalone other income of ₹5.32 crore is 126.3% of profit before tax, so the pre-tax result depends on other income in this quarter.

    The company states it operates as a single business segment, manufacturing and selling plastic laboratory products and certain scientific instruments. The standalone auditors' review reports nothing to suggest the statement was not prepared in accordance with Ind AS 34, with no modification.

    Inference

    The filing reports a one-off statutory impact of new labour codes of ₹1.13 crore in the year ended 31 Mar 2026 as an exceptional item, with no such item in the quarter or half year to 30 Sep 2026. The company says the exact quantification of any further impact will be evaluated once the related rules are notified by the Government.

    The filing shows a standalone investment in subsidiary of ₹9.35 crore in the half year, and a fair value loss on derivative of ₹1.24 crore. It does not say whether any dividend has been declared or proposed on these results, and it does not give the reason for the consolidated loss or the year-on-year fall in standalone profit.

    Filed with BSE on . Reference: Original filing (PDF)

    Disclaimer:

    The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

    Latest posts